- Title
- Remibrutinib (Rhapsido) for chronic spontaneous urticaria
- Creators
- Erica N. Lamkin - Sylvester Comprehensive Cancer CenterEduardo Bravo - Sylvester Comprehensive Cancer CenterJustin Taylor - Sylvester Comprehensive Cancer Center
- Publication Details
- Trends in pharmacological sciences (Regular ed.), Vol.47(7)
- Publisher
- Elsevier Ltd; CAMBRIDGE
- Number of pages
- 2
- Grant note
- National Institute of General Medical Sciences (NIGMS) /National Institutes of Health (NIH): R35GM151109 National Cancer Institute (NCI) /NIH: R01CA292653 Florida Department of Health Bankhead Coley Cancer Research Program: 24B15 Edward P. Evans Foundation NIGMS/NIH: T32GM145462
Acknowledgments J.T. is supported by the National Institute of General Medical Sciences (NIGMS) /National Institutes of Health (NIH) (grant number R35GM151109) , National Cancer Institute (NCI) /NIH (grant number R01CA292653) , the Florida Department of Health Bankhead Coley Cancer Research Program (grant number 24B15) , and the Edward P. Evans Foundation. E.N.L. is supported by the NIGMS/NIH (grant number T32GM145462) .
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 42168043
- Record Identifier
- 991033100911402976
Journal article
Remibrutinib (Rhapsido) for chronic spontaneous urticaria
Trends in pharmacological sciences (Regular ed.), Vol.47(7)
2026-05-21
PMID: 42168043
Metrics
3 Record Views